Arthneeti
Sale is live|00:00:00

Hindustan Unilever Ltd Q1 FY27 Earnings Analysis

Published 3 Jul 2026 | Diversified FMCG | Market Cap: ₹5.3L Cr

Price

2,174

Market Cap

₹5.3L Cr

P/E Ratio

48.9

Revenue Rank

Rank 4

Margin Rank

Rank 3

Earnings Summary

- Confident of better FY'27 performance than FY'26, expecting continued revenue growth driven by volume (Page 13, 22, 31). - Focus on competitive volume-led growth as top priority (Pages 13, 22). - Expect to navigate volatile input costs through pricing actions (2%-5% increases taken) and cost savings, maintaining EBITDA margins within guided band of 22.5%-23.5% (Pages 13, 21, 31). - Double-digit growth targeted in premium and growth portfolios such as Beauty & Wellbeing (Masstige portfolio at Rs. - FY’27 outlook is positive with confidence in better performance than FY’26. - Topline growth expected, driven by volume-led growth and ongoing portfolio transformation. - Pricing actions (2-5% increases so far) will continue to manage cost inflation while balancing volume growth. - EBITDA margin guidance maintained in the band of 22.5% to 23.5%, with operating leverage and cost optimization. - Profit After Tax expected to grow, supported by volume growth and operational efficiencies. - Robust balance sheet and strong cash flows support sustainable investments and shareholder returns. - Key growth drivers include premiumization in Personal Care, expansion in Beauty & Wellbeing (e.g., Minimalist at Rs.

📊 Revenue & Sales Performance

Rank 4

- Confident of better FY'27 performance than FY'26, expecting continued revenue growth driven by volume (Page 13, 22, 31). - Focus on competitive volume-led growth as top priority (Pages 13, 22). - Expect to navigate volatile input costs through pricing actions (2%-5% increases taken) and cost savings, maintaining EBITDA margins within guided band of 22.5%-23.5% (Pages 13, 21, 31). - Double-digit growth targeted in premium and growth portfolios such as Beauty & Wellbeing (Masstige portfolio at Rs. 1,200 crores ARR), Personal Care premium products, Home Care liquids, and Lifestyle Nutrition (Pages 7, 8, 10, 15). - Expansion in penetration of niche formats in Skin Care (sunscreens, light moisturizers, face washes) and new segments like RTD and protein in Lifestyle Nutrition (Pages 29, 16). - Omnichannel and Quick Commerce capabilities are being scaled up to support growth (Pages 7, 21, 28). - Continuous portfolio premiumization and market development to sustain volume gains (Pages 16, 29).

📈 Profitability & Margins

Rank 3

- FY’27 outlook is positive with confidence in better performance than FY’26. - Topline growth expected, driven by volume-led growth and ongoing portfolio transformation. - Pricing actions (2-5% increases so far) will continue to manage cost inflation while balancing volume growth. - EBITDA margin guidance maintained in the band of 22.5% to 23.5%, with operating leverage and cost optimization. - Profit After Tax expected to grow, supported by volume growth and operational efficiencies. - Robust balance sheet and strong cash flows support sustainable investments and shareholder returns. - Key growth drivers include premiumization in Personal Care, expansion in Beauty & Wellbeing (e.g., Minimalist at Rs. 850 cr ARR), and market development in Home Care liquids and Lifestyle Nutrition. - Focus on omni-channel execution, especially Quick Commerce and general trade, to capture evolving consumer behavior. - No specific EPS guidance disclosed, but operational confidence indicates improved earnings per share.

🏗️ Capital Expenditure Plans

Yes

- Hindustan Unilever Limited has planned a **Rs. 2,000 crores capital expenditure** focused on expanding capacity in **premium formats** across Home Care, Personal Care, and Beauty categories. - The company has deployed **Rs. 3,500 crores into bolt-on acquisitions** to strengthen its presence in fast-evolving demand spaces, including digital-first premium Beauty & Wellbeing platforms like Minimalist and OZiva. - The strategic investments reflect HUL's focus on **building businesses of the future**, emphasizing portfolio premiumization and growth acceleration. - The capex and acquisitions are part of HUL's sharpened capital allocation to simultaneously **fuel growth and sustain strong shareholder returns**.

💰 Fundraising & Capital Structure

No information

- Hindustan Unilever Limited (HUL) has not indicated any new fundraising through debt or equity in the March Quarter & Financial Year 2026 earnings call transcript. - The company has focused on capital allocation by deploying Rs. 3,500 crores into bolt-on acquisitions and signing off on Rs. 2,000 crores planned capex investment for premium formats expansion. - HUL's robust financial position includes total reserves of close to Rs. 49,000 crores and strong cash flow from operations around Rs. 10,500 crores. - The company is directing capital toward growth opportunities and maintaining sustainable shareholder returns. - No explicit mention of raising new debt or equity was made during the call. The financial strategy stresses using existing resources for investments and acquisitions.

📋 Order Book & Pipeline

No information

The provided pages from the Hindustan Unilever Limited March Quarter & Financial Year 2026 Earnings Call transcript do not contain specific information related to the company's current or expected order book or pending orders. The discussion primarily covers: - Market share and volume growth in product categories like Bodywash and Tea. - Commodity price inflation and pricing strategy amidst cost pressures. - Investments in Go-To-Market capabilities including Quick Commerce and premium formats. - Margin guidance and handling of input cost volatility. - Strategic capital allocation toward bolt-on acquisitions and capacity expansion. - Market development, premiumization, omni-channel approach, and brand building. There is no explicit mention of order book size, pending orders, or related backlog metrics in the provided document excerpts.

Key Metrics

Revenue

Rank 4

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

No information

Frequently Asked Questions

What were Hindustan Unilever Ltd Q1 FY27 results?

- Confident of better FY'27 performance than FY'26, expecting continued revenue growth driven by volume (Page 13, 22, 31). - Focus on competitive volume-led growth as top priority (Pages 13, 22). - Expect to navigate volatile input costs through pricing actions (2%-5% increases taken) and cost savings, maintaining EBITDA margins within guided band of 22.5%-23.5% (Pages 13, 21, 31). - Double-digit growth targeted in premium and growth portfolios such as Beauty & Wellbeing (Masstige portfolio at Rs. - FY’27 outlook is positive with confidence in better performance than FY’26. - Topline growth expected, driven by volume-led growth and ongoing portfolio transformation. - Pricing actions (2-5% increases so far) will continue to manage cost inflation while balancing volume growth. - EBITDA margin guidance maintained in the band of 22.5% to 23.5%, with operating leverage and cost optimization. - Profit After Tax expected to grow, supported by volume growth and operational efficiencies. - Robust balance sheet and strong cash flows support sustainable investments and shareholder returns. - Key growth drivers include premiumization in Personal Care, expansion in Beauty & Wellbeing (e.g., Minimalist at Rs.

What is Hindustan Unilever Ltd share price analysis?

Hindustan Unilever Ltd currently shows a neutral. The stock trades at a P/E of 48.9 with a market cap of ₹533,874. Investors should review the full earnings analysis for detailed insights.

Is Hindustan Unilever Ltd planning capital expenditure?

- Hindustan Unilever Limited has planned a **Rs.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.